web analytics

UPDATED: Did Dr. Andrew Brill FBI Flip on Johnson & Johnson to Save His Own FlapJACK-Ass?

UPDATED: Did Dr. Andrew Brill FBI Flip on Johnson & Johnson to Save His Own FlapJACK-Ass?

UPDATED May 28, 2015 Below 

F.B.I. Investigates Whether Harm From Surgical Power Tool Was Ignored

August 25, 2014





Dr. Andrew Brill recently stepped down from a

Food & Drug Administration safety panel due to a serious conflict of interest. 

Womens Surgery Group

Johnson & Johnson’s Ethicon’s Gynecare (one the world’s largest producers of transvaginal mesh) in 2011 paid ($150,000) to consulting doctor, Dr. Andrew Brill, who also sat on the FDA committee panel that consulted on the now very controversial transvaginal mesh, despite a very clear conflict of interest. 

(Dr. Brill is an accomplice to Johnson & Johnson’s Ethicon’s Gynecare’s unethical and illegal activity)*

That’s bad enough in and of itself, except it almost happened for a second known time again this year (2014) when Dr. Andrew Brill (now paid almost $213,000) for consulting for Johnson & Johnson’s Ehticon’s Gynecare as he again was simultaneously consulting for the FDA committee panel over the controversial possible cancer causing morecellators, until the Wall Street Journal intervened the night before the FDA meeting.

(The Wall Street Journal, by exposing the truth, forced accountability from Dr. Brill and the FDA (sort of-how did they not know?-but who will force accountability on Johnson & Johnson’s Ethicon’s Gynecare for their known involvement?)

During the course of the agency’s review and in consultation with Dr. Andrew Brill, it was determined that the financial information he disclosed was just above the threshold established for panel members to participate in one of our meetings,” an FDA spokeswoman told the Wall Street Journal’s Jennifer Levitz.

(Johnson & Johnson’s Ethicon’s Gynecare was encouraging, replicating and rewarding (paid more than in 2011) Dr. Brill’s unethical and illegal behavior)*  Unchecked pathological sociopathic behavior will continue until there is forced accountability with severe penalties (jail) and deterring factors (I will share my ideas for that on a future post) are fully implemented.

(Johnson & Johnson seems to only release press releases to the Wall Street Journal (accomplices) which cuts down on the amount of negative coverage stories since major outlets will likely not want to cite the WSJ as their source)*

It wasn’t until the Sunshine Act signed into law by President Obama under the Affordable Care Act (ACA) on March 23, 2010, were pharmaceutical/medical device companies required to report such financial arrangements with physicians/consultants became available.

*The fundamental elements that support Johnson & Johnson’s Ethicon’s Gynecare’s entrenched use The Sociopathic Business Model™.  All accomplices eventually become victims in this business model so it will be interesting to see what the outcome will be for many.  

Checklist-of-Characteristic-of-The-Sociopathic-Business-Model (1)

As patients (many of whom have been harmed), consumers, employees and taxpayers alike we have the right to know why the FDA had not figured out Dr. Brill’s involvement with both Johnson & Johnson (JNJ) and their own panel prior to the WSJ exposing the facts? And now that the FDA is aware, how with the DOJ force accountability Dr. Brill, Johnson & Johnson’s Ethicon’s Gynecare and the FDA?


Updated May 28, 2015

According to The New York Times:

The Federal Bureau of Investigation has begun looking into whether medical device makers, doctors and hospitals broke the law by failing to report problems linked to a power tool used during gynecologic surgery, according to two people who said they were interviewed by investigators.

The tool, called a morcellator, has rapidly spinning blades that cut tissue into pieces that can be removed from the body through the tiny slits made during minimally invasive surgery. Morcellators have often been used in surgery to remove the uterus, but in some women with undetected cancers they have sprayed malignant cells around inside the abdomen like seeds, speeding the progression of the disease.

The inquiries were first reported on Wednesday by The Wall Street Journal, which said the agents worked out of the F.B.I. office in Newark, N.J.

Celeste Danzi, a spokeswoman for the F.B.I.’s Newark office, declined to confirm the inquiry. “We just don’t comment on the existence or nonexistence of any investigation,” she said.

Well, it’s likely we now know why Dr. Andrew Brill was never arrested or indicted, did he FBI flip on Johnson & Johnson to save his own flapjack-ass?

Johnson & Johnson’s Ethicon’s Gynecare’s “Withdrawing” Decision on Morecellators

Johnson & Johnson Keep Meshing Up & Now Potential to Spread Cancer DEMAND A RECALL


4th of July Big Business in Bed With Big Media: JNJ & WSJ Hobby Lobby Case Study

1 Comment
  • Good work Melayna. The FDA is so in bed with J&J! Gave J&J extra time to present their profit driven perspective while limiting doctors speaking out against mesh to 5 minutes each at the FDA Obgyn Panel meeting in September 8-9, 2011 meeting. And they added Brill, Dr. Cheryl Iglesias, Dr. George Flesh and other J&J paid docs to the panel. Corruption to protect plastic (polypropylene) that kills and maims women. Really sick in my opinion.

    May 29, 2015 at 8:40 pm

Post a Comment